Document: Product Management Service (PMS) – Frequently Asked Questions (FAQs)-2026/4/23

Page: Podcast: Inside EMA-2026/4/23

Page: Referentials Management Service (RMS)-20256/4/23

Page: Procurement and grants-2026/4/22

Document: Clinical Data Publication (CDP) - Questions and Answers (Q&As) on the European Medicines Agency policy on the publication of clinical data for medicinal products for human use (Policy 0070) work-share initiative with Health Canada (HC)-2026/4/21

Document: Agenda - PDCO agenda of the 21-24 April 2026 meeting-2026/4/21

Document: Process for the electronic submission of medicinal product information - Chapter 3-2026/4/21

Document: Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9-2026/4/21

Document: Opinion of the CVMP on the establishment of maximum residue limits: Lidocaine (EMEA/V/MRL/003649/MODF/0004)-2026/4/21

Document: Guidance on the electronic submission of information on investigational medicinal products for human use in the Extended EudraVigilance medicinal product dictionary (XEVMPD)-2026/4/20